Hikal – Standing tall amidst changing paradigms

Hikal's Research & Technology centre in Pune, India
Hikal is a reliable long-term outsourcing partner and supplier of key active ingredients and intermediates to companies in the Pharmaceuticals, Animal Health, Biotech, Crop Protection and Specialty Chemical industries.
The fine chemicals landscape has been continuously evolving over the last three decades. Today, we experience yet again a major paradigm shift in our industry. One of the recent triggers has been Covid, accelerating ongoing trends such as consolidation and balancing supply chains, big pharma companies intensifying their outsourcing activities, different kinds of drugs and requirements for APIs driven by personalized medicine, biologicals and recently, oligonucleotides such as mRNA vaccines.
Being a major player in the Pharmaceuticals and Crop Protection global industry, Hikal is actively driving fundamental change. Since its foundation in 1988 by our Executive Chairman, Jai Hiremath, Hikal has come a long way and defines itself today as a technology and customer orientation driven provider. Our pristine track record of 33 years, a strong R&D capability and focus on technology with regulatory compliance and good corporate governance has ensured long-standing sustainable business relationships with our customers, globally.
With a total reactor capacity of over 3800 m3 across five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology centre at Pune, Hikal has successfully established a strong foothold in multiple businesses – Pharmaceuticals, Crop Protection, Animal Health, Food Ingredients and Specialty Chemicals.
Hikal is a leading manufacturer of intermediates and APIs with capability spanning from an R&D to a pilot scale, before gradually scaling up our capacity to the commercial stage. Our facilities have been inspected and certified by the Global Regulatory Authorities including the USFDA and we proudly stand out as one of the few Indian manufacturers that has an impeccable regulatory track record with the global authorities.
Sustainability has been a key priority for Hikal and we have always strived to have best-in-class EHS standards. We have undertaken various technology enabled initiatives to strengthen the Company’s journey towards driving sustainability, improving our customer experience and capitalizing on growth. People make the difference and at Hikal, our employees' commitment to excellence is what differentiates us from others.
Explore our technology platform, the skills of our people and rate us on the results and value we are constantly delivering to our customers and partners.

Related News
-
Sponsored Content IFF Pharma Solutions: Paving the Way for Superior Suspensions
Shawn Branning, Global Strategic Marketing Manager at IFF – Pharma Solutions -
News Greenfield Global Ireland Ready to Supply Life Science Customers Globally
New facility aims to serve local and global pharmaceutical customers with high-purity ethanol, ethanol blends and buffer solutions -
News Rare diseases care pathway: a major challenge to harmonize patient management
In France, rare diseases are numerous: between 7,000 and 8,000 diseases are currently accounted for, and concern more than 3 million French people, accounting for almost 4,5% of the total population. The organization of screening and care for these ill... -
Sponsored Content CPHI Podcast Series: Selecting the Right CDMO Outsourcing Partner
Sponsors within the biopharmaceutical industry are increasingly turning to outsourcing for several reasons; remaining competitive and flexible within a quickly evolving sector, gaining access to manufacturing capacity and state-of-the-art equipment and... -
Sponsored Content Sterile manufacturing Annex 1 amendments: what, why and how explained
In January 2020 the European Commission published some proposed significant revisions to Annex 1, the EU’s good manufacturing practice (GMP) guide for the manufacture of sterile products. In the following three-month consultation period, affected... -
News Recipharm expands its analytical services offering in India
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions -
News Tikun Olam-Cannbit and Wavelength strike novel cannabis agreement
Firms say the partnership will "multiply the power of both companies, the pharmaceutical industry and the medical cannabis industry" -
News Pharmapack interviews Serkan Oray of UCB Pharma
Ahead of Pharmapack Europe 2021 in October, we talk to one of the speakers, Serkan Oray, Vice President, Devices, Packaging & Wearable Technologies at UCB Pharma about the company's new electromechanical injection device and the innovation drive wi...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance